Barry Investment Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.54M | Sell |
19,781
-71
| -0.4% | -$8.31K | 0.53% | 31 |
|
|
2026
Q1 | $2.4M | Sell |
19,852
-2
| -0% | -$231 | 0.53% | 32 |
|
|
2025
Q4 | $2.09M | Buy |
19,854
+181
| +0.9% | +$17K | 0.47% | 36 |
|
|
2025
Q3 | $1.65M | Buy |
19,673
+901
| +5% | +$74.2K | 0.38% | 43 |
|
|
2025
Q2 | $1.5M | Buy |
18,772
+6,249
| +50% | +$497K | 0.37% | 44 |
|
|
2025
Q1 | $1.13M | Buy |
12,523
+175
| +1% | +$16.3K | 0.3% | 46 |
|
|
2024
Q4 | $1.24M | Sell |
12,348
-541
| -4% | -$55.8K | 0.4% | 40 |
|
|
2024
Q3 | $1.46M | Buy |
12,889
+227
| +2% | +$27K | 0.45% | 37 |
|
|
2024
Q2 | $1.58M | Sell |
12,662
-31
| -0.2% | -$3.99K | 0.53% | 34 |
|
|
2024
Q1 | $1.68M | Sell |
12,693
-218
| -2% | -$26.9K | 0.56% | 35 |
|
|
2023
Q4 | $1.42M | Buy |
12,911
+124
| +1% | +$12.9K | 0.48% | 38 |
|
|
2023
Q3 | $1.33M | Sell |
12,787
-120
| -0.9% | -$12.9K | 0.48% | 41 |
|
|
2023
Q2 | $1.5M | Sell |
12,907
-601
| -4% | -$68.2K | 0.51% | 38 |
|
|
2023
Q1 | $1.45M | Sell |
13,508
-439
| -3% | -$47.4K | 0.47% | 39 |
|
|
2022
Q4 | $1.55M | Sell |
13,947
-294
| -2% | -$30.1K | 0.49% | 38 |
|
|
2022
Q3 | $1.24M | Buy |
14,241
+43
| +0.3% | +$3.84K | 0.42% | 41 |
|
|
2022
Q2 | $1.3M | Sell |
14,198
-552
| -4% | -$48.9K | 0.39% | 43 |
|
|
2022
Q1 | $1.22M | Buy |
14,750
+377
| +3% | +$29.7K | 0.32% | 48 |
|
|
2021
Q4 | $1.11M | Buy |
14,373
+288
| +2% | +$22.9K | 0.29% | 50 |
|
|
2021
Q3 | $1.07M | Buy |
14,085
+541
| +4% | +$41.1K | 0.3% | 47 |
|
|
2021
Q2 | $1.06M | Buy |
13,544
+1,275
| +10% | +$94.8K | 0.28% | 47 |
|
|
2021
Q1 | $909K | Buy |
12,269
+1,492
| +14% | +$110K | 0.25% | 53 |
|
|
2020
Q4 | $847K | Buy |
10,777
+2,432
| +29% | +$186K | 0.25% | 43 |
|
|
2020
Q3 | $665K | Buy |
8,345
+1,175
| +16% | +$92K | 0.23% | 41 |
|
|
2020
Q2 | $531K | Buy |
+7,170
| New | +$540K | 0.19% | 46 |
|
|
2019
Q1 | – | Sell |
-106,385
| Closed | -$7.76M | – | 78 |
|
|
2018
Q4 | $7.76M | Buy |
106,385
+599
| +0.6% | +$42.3K | 2.9% | 13 |
|
|
2018
Q3 | $7.16M | Buy |
105,786
+1,001
| +1% | +$63.8K | 2.41% | 19 |
|
|
2018
Q2 | $6.07M | Buy |
104,785
+3,584
| +4% | +$202K | 2.33% | 19 |
|
|
2018
Q1 | $5.26M | Buy |
101,201
+261
| +0.3% | +$14.1K | 1.99% | 19 |
|
|
2017
Q4 | $5.42M | Buy |
100,940
+243
| +0.2% | +$13.5K | 2.01% | 18 |
|
|
2017
Q3 | $6.15M | Sell |
100,697
-117
| -0.1% | -$7.09K | 2.27% | 17 |
|
|
2017
Q2 | $6.17M | Buy |
100,814
+386
| +0.4% | +$23.5K | 2.33% | 17 |
|
|
2017
Q1 | $6.09M | Sell |
100,428
-636
| -0.6% | -$38.6K | 2.26% | 18 |
|
|
2016
Q4 | $5.68M | Sell |
101,064
-1,600
| -2% | -$93.6K | 1.99% | 20 |
|
|
2016
Q3 | $6.11M | Sell |
102,664
-45,695
| -31% | -$2.67M | 2.1% | 19 |
|
|
2016
Q2 | $8.15M | Sell |
148,359
-1,306
| -0.9% | -$69.5K | 3.17% | 12 |
|
|
2016
Q1 | $7.56M | Buy |
149,665
+3,852
| +3% | +$189K | 2.4% | 14 |
|
|
2015
Q4 | $7.35M | Sell |
145,813
-5,380
| -4% | -$271K | 2.39% | 15 |
|
|
2015
Q3 | $7.13M | Sell |
151,193
-1,758
| -1% | -$93.4K | 2.28% | 15 |
|
|
2015
Q2 | $8.31M | Buy |
152,951
+663
| +0.4% | +$37.2K | 8.36% | 6 |
|
|
2015
Q1 | $8.35M | Sell |
152,288
-7,458
| -5% | -$422K | 2.55% | 14 |
|
|
2014
Q4 | $8.66M | Buy |
+159,746
| New | +$8.9M | 2.81% | 12 |
|
Other funds holding MRK
ECSS
Barry Investment Advisors's MRK Position: Q2 2026 in Review
Barry Investment Advisors reduced its Merck (MRK) stake by 0.36% in Q2 2026, selling an estimated $8.31K and leaving 19,781 shares worth $2.54M. The position accounts for 0.53% of the portfolio, ranked #31.
Barry Investment Advisors first reported a position in MRK in Q4 2014 and has held it in 42 quarters since. The position peaked at $8.66M in Q4 2014. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Barry Investment Advisors held 19,781 shares of Merck worth $2.54M as of Q2 2026.
- Barry Investment Advisors sold 71 Merck shares in Q2 2026, an estimated $8.31K.
- Merck made up 0.53% of Barry Investment Advisors's portfolio in Q2 2026, its #31 holding.
- Barry Investment Advisors first reported a position in Merck in Q4 2014 and has held it in 42 quarters since.
- Barry Investment Advisors's Merck position peaked at $8.66M in Q4 2014.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.